Evidence map›Paper›PMID 26191605›Full record

ArticleAntioxidants & redox signaling2015

Converting a Sulfenic Acid Reductase into a Disulfide Bond Isomerase.

Claire Chatelle, Stéphanie Kraemer, Guoping Ren, Hannah Chmura, Nils Marechal, Dana Boyd, Caroline Roggemans, Na Ke, Paul Riggs, James Bardwell and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Antioxidants & redox signaling, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Claire Chatelle1 Protein Expression and Modification, New England Biolabs, Ipswich, Massachusetts.
Stéphanie Kraemer1 Protein Expression and Modification, New England Biolabs, Ipswich, Massachusetts.
Guoping Ren1 Protein Expression and Modification, New England Biolabs, Ipswich, Massachusetts.
Hannah Chmura1 Protein Expression and Modification, New England Biolabs, Ipswich, Massachusetts.
Nils Marechal1 Protein Expression and Modification, New England Biolabs, Ipswich, Massachusetts.
Dana Boyd3 Department of Microbiology and Immunobiology, Harvard Medical School , Boston, Massachusetts.
Caroline Roggemans1 Protein Expression and Modification, New England Biolabs, Ipswich, Massachusetts.
Na Ke1 Protein Expression and Modification, New England Biolabs, Ipswich, Massachusetts.
Paul Riggs1 Protein Expression and Modification, New England Biolabs, Ipswich, Massachusetts.
James Bardwell5 Howard Hughes Medical Institute Molecular, Cellular and Developmental Biology, University of Michigan , Ann Arbor, Michigan.
Mehmet Berkmen1 Protein Expression and Modification, New England Biolabs, Ipswich, Massachusetts.
Protein Express (United States) · USHarvard University · USHoward Hughes Medical Institute · USNovartis (Switzerland) · CH

Funding

Microbial Diversity in Mechanisms of Disulfide Bond Formation and ReductionR01GM041883 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI BOYD, DANA · 1989 to 2014
$7.8M
NIGMS NIH HHS R01 GM041883
6 · The paper itself

Abstract

aimsPosttranslational formation of disulfide bonds is essential for the folding of many secreted proteins. Formation of disulfide bonds in a protein with more than two cysteines is inherently fraught with error and can result in incorrect disulfide bond pairing and, consequently, misfolded protein. Protein disulfide bond isomerases, such as DsbC of Escherichia coli, can recognize mis-oxidized proteins and shuffle the disulfide bonds of the substrate protein into their native folded state.

resultsWe have developed a simple blue/white screen that can detect disulfide bond isomerization in vivo, using a mutant alkaline phosphatase (PhoA*) in E. coli. We utilized this screen to isolate mutants of the sulfenic acid reductase (DsbG) that allowed this protein to act as a disulfide bond isomerase. Characterization of the isolated mutants in vivo and in vitro allowed us to identify key amino acid residues responsible for oxidoreductase properties of thioredoxin-like proteins such as DsbC or DsbG. INNOVATION AND

conclusionsUsing these key residues, we also identified and characterized interesting environmental homologs of DsbG with novel properties, thus demonstrating the capacity of this screen to discover and elucidate mechanistic details of in vivo disulfide bond isomerization.

Indexed as

MutationProtein FoldingAlkaline PhosphataseAmino AcidsCopperDisulfidesEscherichia coliGenetic TestingOxidoreductasesProtein Disulfide-IsomerasesRibonuclease, PancreaticSulfenic AcidsAlkaline PhosphataseAmino AcidsCopperDisulfidesOxidoreductasesProtein Disulfide-IsomerasesRibonuclease, PancreaticSulfenic Acids

Identifiers

PMID26191605
PMCPMC4624244
OpenAlexW1608931928

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.